Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Schrezenmeier JF"'
Autor:
Klever MK; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany., Sträng E; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Hetzel S; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany., Jungnitsch J; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany.; Human Molecular Genomics Group, Max Planck Institute for Molecular Genetics, Berlin, Germany., Dolnik A; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Schöpflin R; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany.; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany., Schrezenmeier JF; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Schick F; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Blau O; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Labor Berlin - Charité Vivantes GmbH, Berlin, Germany., Westermann J; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Labor Berlin - Charité Vivantes GmbH, Berlin, Germany., Rücker FG; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Xia Z; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Schrezenmeier H; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm, Germany., Spielmann M; Human Molecular Genomics Group, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Institut für Humangenetik Lübeck, Universität zu Lübeck, Lübeck, Germany., Meissner A; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany., Melo US; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany., Mundlos S; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany.; Labor Berlin - Charité Vivantes GmbH, Berlin, Germany., Bullinger L; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6520-6531.
Autor:
Denkinger CM; Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany. Claudia.Denkinger@uni-heidelberg.de.; Partner site Heidelberg University Hospital, German Center for Infection Research, Heidelberg, Germany. Claudia.Denkinger@uni-heidelberg.de., Janssen M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Schäkel U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Gall J; NCT Trial Center, National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany., Leo A; Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany., Stelmach P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Weber SF; Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany., Krisam J; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany., Baumann L; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany., Stermann J; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany., Merle U; Department of Internal Medicine IV, Heidelberg University Hospital, Heidelberg, Germany., Weigand MA; Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany., Nusshag C; Department of Nephrology, University of Heidelberg, Heidelberg, Germany., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Schrezenmeier JF; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Bornhäuser M; Department of Internal Medicine I, University Hospital Dresden and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany., Alakel N; Department of Internal Medicine I, University Hospital Dresden and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany., Witzke O; Department of Infectious Diseases, West German Centre for Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Wolf T; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany., Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany., Schmiedel S; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Addo MM; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Partner site Hamburg-Lübeck-Borstel-Riems, German Center for Infection Research, Hamburg, Germany.; University Medical Center Hamburg-Eppendorf, Institute for Infection Research and Vaccine Development, Hamburg, Germany., Herth F; Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany., Kreuter M; Center for Interstitial and Rare Lung Diseases, Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany., Tepasse PR; Department of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, Münster, Germany., Hertenstein B; Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Morgner A; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Kiehl M; Department of Internal Medicine I, Frankfurt (Oder) General Hospital, Frankfurt (Oder), Germany., Hopfer O; Department of Internal Medicine I, Frankfurt (Oder) General Hospital, Frankfurt (Oder), Germany., Wattad MA; Department of Hematology, Oncology, Palliative Care and Stem Cell Transplantation, Klinikum Hochsauerland, Meschede, Germany., Schimanski CC; Department of Internal Medicine II, Klinikum Darmstadt, Darmstadt, Germany., Celik C; Department of Internal Medicine II, Klinikum Darmstadt, Darmstadt, Germany., Pohle T; Department of Internal Medicine I, Klinikum Herford, Herford, Germany., Ruhe M; Department of Internal Medicine I, Klinikum Herford, Herford, Germany., Kern WV; Department of Medicine II, Division of Infectious Diseases and Travel Medicine, University Medical Centre Freiburg, Freiburg, Germany., Schmitt A; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Lorenz HM; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Souto-Carneiro M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Gaeddert M; Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany., Halama N; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Department of Translational Immunotherapy (D240), German Cancer Research Center, Heidelberg, Germany.; Helmholtz Institute for Translational Oncology, Mainz, Germany., Meuer S; Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany., Kräusslich HG; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany., Müller B; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany., Schnitzler P; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany., Parthé S; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany., Bartenschlager R; Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, Heidelberg, Germany., Gronkowski M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Klemmer J; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Schmitt M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Dreger P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Kriegsmann K; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Schlenk RF; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; NCT Trial Center, National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. carsten.mueller-tidow@med.uni-heidelberg.de.; National Center for Tumor Diseases, Heidelberg, Germany. carsten.mueller-tidow@med.uni-heidelberg.de.
Publikováno v:
Nature cancer [Nat Cancer] 2023 Jan; Vol. 4 (1), pp. 96-107. Date of Electronic Publication: 2022 Dec 29.
Autor:
Riesner K; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., Shi Y; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., Jacobi A; Biotechnology Center, and., Kräter M; University Clinic Carl Gustav Carus Dresden, Medical Clinic and Polyclinic 1, Technical University Dresden, Dresden, Germany; and., Kalupa M; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., McGearey A; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., Mertlitz S; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., Cordes S; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., Schrezenmeier JF; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Mengwasser J; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., Westphal S; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany., Perez-Hernandez D; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Schmitt C; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Dittmar G; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Guck J; Biotechnology Center, and., Penack O; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany.
Publikováno v:
Blood [Blood] 2017 Apr 06; Vol. 129 (14), pp. 2021-2032. Date of Electronic Publication: 2017 Jan 17.